SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 80 filers reported holding SERES THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 500 | -6.4% | 0.00% | – |
| Q4 2019 | $2,000 | -60.0% | 534 | -58.4% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -44.4% | 1,284 | 0.0% | 0.00% | – |
| Q1 2019 | $9,000 | +80.0% | 1,284 | 0.0% | 0.00% | – |
| Q4 2018 | $5,000 | -50.0% | 1,284 | 0.0% | 0.00% | – |
| Q3 2018 | $10,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q2 2018 | $10,000 | 0.0% | 1,284 | 0.0% | 0.00% | – |
| Q1 2018 | $10,000 | -33.3% | 1,284 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | +15.4% | 1,284 | 0.0% | 0.00% | – |
| Q4 2016 | $13,000 | -13.3% | 1,284 | 0.0% | 0.00% | – |
| Q3 2016 | $15,000 | -6.2% | 1,284 | +140.4% | 0.00% | – |
| Q2 2016 | $16,000 | +14.3% | 534 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | -22.2% | 534 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | +12.5% | 534 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | – | 534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
| Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
| Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
| Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
| Knott David M Jr | 470,000 | $2,251 | 0.90% |
| GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
| Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
| Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
| Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
| Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |